Lupin inks pact with Exeltis to promote Solosec drug in US

Lupin inks pact with Exeltis to promote Solosec drug in US

AgenciesUpdated: Thursday, January 27, 2022, 09:53 PM IST
article-image
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products. |

Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.

As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.

Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.

''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.

(With inputs from PTI)

RECENT STORIES

Union Budget 2026 Signals Long-Term Growth: Aviation CEOs
Union Budget 2026 Signals Long-Term Growth: Aviation CEOs
Union Budget 2026: ‘Humpty Dumpty And Directionless,' Says West Bengal CM Mamata Banerjee | VIDEO
Union Budget 2026: ‘Humpty Dumpty And Directionless,' Says West Bengal CM Mamata Banerjee | VIDEO
Union Budget 2026–27 Boosts Real Estate With ₹12.2 Lakh Cr Infra Push: Industry Leaders
Union Budget 2026–27 Boosts Real Estate With ₹12.2 Lakh Cr Infra Push: Industry Leaders
'Gaon Gaon Ka Khush Ho Jayega Bachaa': Union Minister Ramdas Athawale's Poetic Reaction To Budget...
'Gaon Gaon Ka Khush Ho Jayega Bachaa': Union Minister Ramdas Athawale's Poetic Reaction To Budget...
Union Budget 2026: ‘Adding Salt To Maharashtra’s Wounds,' Says Congress Leader Vijay Wadettiwar...
Union Budget 2026: ‘Adding Salt To Maharashtra’s Wounds,' Says Congress Leader Vijay Wadettiwar...